DINNER SYMPOSIA

Discover how genomics is moving from research into everyday clinical practice and learn how precision medicine is being used to:

• Support equitable and personalised treatment decisions from diagnosis through to medicines optimisation.

• Improve prescribing safety and effectiveness through.

• Enable lifelong use of genomic information across healthcare settings.

• Predict treatment-related complications in vulnerable patient populations.

• Harness real-world and longitudinal data to improve patient outcomes, including symptom management.

This dinner symposium offers a unique opportunity to learn from experts at the forefront of implementing precision medicine in both the UK and Australian healthcare systems.

Implementation of pharmacogenomics in UK primary care – designing for lifetime usability across systems

• Jessica Keen, Christie NHS Foundation Trust, United Kingdom.

Australian perspective on pharmacogenomic testing and the use of “big data” in cancer care

• Claire Moore, Murdoch Children’s Research Institute (MCRI) Melbourne, Australia.

• Marissa Ryan, Princess Alexandra Hospital and CPG Chair

• Kate Wright,  NSW Health, CPG Executive Member and ASM Program Committee CPG representative

• Jessica Keen, Wellcome 4Ward North clinical PhD fellow, Christie NHS Foundation Trust, United Kingdom

• Claire Moore, Clinical Pharmacogenomics Pharmacist Cancer Therapies Research Group, Murdoch Children’s Research Institute

• $75 for delegates

• $200 for non-delegates.